Coverage dated November 5, 2026 to November 6, 2026
ER-Negative Breast Cancer Risk Linked with Blood Levels of Two PFAS Forever Chemicals
Headline from Geneng News
The results of a study found that women with higher blood levels of two common PFAS were more likely to develop estrogen receptor-negative breast cancer, saying their results have important public health implications.
Geneng News's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Women with higher blood levels of two common per- and polyfluoroalkyl substances, also familiarly known as PFAS, were more likely to develop estrogen receptor-negative, or ER-negative, breast cancer, according to a new study by the National Institutes of Health (NIH), part of the U.S.
The results of a study found that women with higher blood levels of two common PFAS were more likely to develop estrogen receptor-negative breast cancer, saying their results have important public health implications.
